Real-time US stock institutional ownership tracking and fund flow analysis to understand who owns and is buying specific stocks in the market. We monitor 13F filings and institutional buying patterns because large investors often have superior information and research capabilities. We provide ownership data, fund flow analysis, and institutional positioning for comprehensive coverage. Follow institutional money with our comprehensive ownership tracking and analysis tools for smarter investment decisions.
ProMIS Neurosciences Inc. Common Shares (ON) (PMN) is trading at $10.88 as of 2026-04-08, marking a 0.73% decline in its latest session. This analysis explores key technical levels, prevailing market context, and potential near-term scenarios for the biotech stock, without providing investment recommendations or price forecasts. PMN’s recent price action has been largely range-bound, with limited company-specific news driving flows as of late, leading market participants to focus on technical ma
How does currency impact ProMIS (PMN) Stock | Price at $10.88, Down 0.73% - Low Risk Entry
PMN - Stock Analysis
4211 Comments
1816 Likes
1
Zymaire
New Visitor
2 hours ago
I read this and now everything feels connected.
👍 262
Reply
2
Fayden
Consistent User
5 hours ago
Interesting insights — the analysis really highlights the key market drivers.
👍 206
Reply
3
Rhon
Experienced Member
1 day ago
Ah, such bad timing.
👍 17
Reply
4
Kinberly
Consistent User
1 day ago
Clear explanations of market dynamics make this very readable.
👍 215
Reply
5
Furkan
Active Reader
2 days ago
This feels like a turning point.
👍 238
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.